Evelo Biosciences, Inc. (EVLO)

Evelo Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	17.26	47.94	68.44	68.86	77.83	147.92
Short-Term Investments	0	0	0	0	0	54.82
Cash & Cash Equivalents	17.26	47.94	68.44	68.86	77.83	147.92
Cash Growth	-75.00%	-29.95%	-0.60%	-11.53%	-47.38%	286.76%
Other Current Assets	1.67	3.63	2.59	0	0	-54.82
Total Current Assets	18.94	51.57	71.03	68.86	77.83	147.92
Property, Plant & Equipment	0.89	11.71	15.53	18.24	8.34	6.93
Other Long-Term Assets	0.8	1.16	1.31	3.55	4.75	5.02
Total Long-Term Assets	1.69	12.87	16.85	21.78	13.09	11.95
Total Assets	20.63	64.44	87.87	90.64	90.92	159.87
Accounts Payable	0.53	1.76	1.6	19.83	9.74	9.24
Deferred Revenue	7.5	7.5	13.07	-2.14	0	0
Current Debt	33.95	2.26	1.95	1.67	0	0
Other Current Liabilities	-2.21	0.87	0.74	0.46	0	0
Total Current Liabilities	39.76	12.4	17.36	19.83	9.74	9.24
Long-Term Debt	0	48.88	54.34	40.04	19.63	12.31
Other Long-Term Liabilities	7.57	8.16	7.5	0.28	1.35	1.38
Total Long-Term Liabilities	7.57	57.04	61.84	40.32	20.98	13.68
Total Liabilities	47.33	69.43	79.2	60.15	30.72	22.92
Total Debt	33.95	51.14	56.29	40.04	19.63	12.31
Debt Growth	-38.12%	-9.16%	40.60%	103.92%	59.56%	23.47%
Common Stock	0.02	0.11	0.05	0.05	0.03	0.03
Retained Earnings	-588.03	-529.22	-414.7	-292.52	-198.85	-113.38
Comprehensive Income	0	0	0	0	-90.92	-0.02
Shareholders' Equity	-26.71	-4.99	8.67	30.49	60.2	136.95
Total Liabilities and Equity	20.63	64.44	87.87	90.64	90.92	159.87
Net Cash / Debt	-16.69	-3.2	12.15	28.82	58.2	190.43
Net Cash / Debt Growth	-	-	-57.85%	-50.48%	-69.44%	573.38%
Net Cash Per Share	-0.96	-0.73	4.59	14.60	36.34	174.14
Working Capital	-20.83	39.18	53.66	49.02	68.09	138.68
Book Value Per Share	-1.54	-1.15	3.28	15.44	37.59	125.23

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.